Read More Pharma Industry News FDA approves Eli Lilly’s Kisunla for Alzheimer’s treatment The U.S. Food and Drug Administration (FDA) has approved Kisunla (donanemab-azbt), an Alzheimer’s treatment developed by Eli Lilly… byPallavi MadhirajuJuly 4, 2024